Keywords: roche, granted, tamiflu, priority, review, hoffmann-la, been

Roche granted Tamiflu priority review

Article | 16 September 1999

Hoffmann-La Roche has been granted priority review from HealthCanada for its influenza drug Tamiflu (oseltamavir). Meanwhile, the firm says it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Oseltamivir Phosphate

Tamiflu

capecitabine

Xeloda

Nystatin

Go to drug listing